Quantifying RSV and CD8+ T Cells in Endobronchial Biopsies
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization : Imperial College London
Other organizations : Merck & Co., Inc., Rahway, NJ, USA (United States)
Variable analysis
- Paraformaldehyde fixation and paraffin embedding of endobronchial biopsies
- Staining with mouse anti-RSV antibody cocktail at 1:50 dilution
- Staining with mouse anti-CD8 antibody at 1:100 dilution
- Quantification of RSV-positive cells
- Quantification of CD8+ T cells
- Use of EnVision peroxidase-staining method
- Use of irrelevant mouse IgG1 kappa antibody (MOPC21) as negative control
- Use of RSV-infected A549 cells as positive staining control
- Blinding of operators to sample timing and infection status during quantification
- RSV-infected A549 cells
- Irrelevant mouse IgG1 kappa antibody (MOPC21)
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!